Claims for Patent: 6,140,101

Summary for Patent: 6,140,101

Title:	Polypeptides having L-asparaginase activity
Abstract:	Disclosed are polypeptides which originate from mammal, having L-asparaginase activity. The polypeptides are easily prepared by applying recombinant DNA techniques to DNAs encoding the polypeptides and they exert satisfactory effects in the treatment and/or the prevention for diseases caused by tumor cells dependent on L-asparagine, and cause no substantial serious side effects even when administered to humans in relatively-high dose.
Inventor(s):	Ario; Takeshi (Okayama, JP), Taniai; Madoka (Okayama, JP), Yamamoto; Kozo (Okayama, JP), Kurimoto; Masashi (Okayama, JP)
Assignee:	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (Okayama, JP)
Application Number:	09/195,666
Patent Claims:	1. An isolated DNA molecule encoding a polypeptide exhibiting L-asparaginase activity, comprising a nucleotide sequence selected from the group consisting of SEQ ID NOs: 11 to 14 and fragments of any one of SEO ID NOs:11 to 14 which encode a polypeptide exhibiting L-asparaginase activity. 2. A self-replicable vector, comprising an isolated DNA molecule encoding the polypeptide exhibiting L-asparaginase activity according to claim 1. 3. The self-replicable vector according to claim 2, which is a plasmid vector. 4. The self-replicable vector according to claim 2, further comprising one or more promoters selected from the group consisting of metallothionein and Tac promoters. 5. A host cell transformed with a DNA molecule according to claim 1. 6. A host cell according to claim 5, wherein said host cell is a member selected from the group consisting of prokaryotic and eukarvotic cells. 7. The host cell according to claim 5, wherein said host cell is Escherichia coli. 8. The host cell according to claim 5, wherein said host cell is a mouse cell. 9. A host cell transformed by the self-replicable vector according to claim 2. 10. The host cell according to claim 9, wherein said host cell is a member selected from the group consisting of prokaryotic and eukaryotic cells. 11. The host cell according to claim 9, where in said host cell is Escherichia coli. 12. The host cell according to claim 9, wherein said host cell is a mouse cell. 13. A process for preparing a polypeptide exhibiting L-asparaginase activity, comprising the steps of: expressing a DNA molecule encoding the polypeptide according to claim 1; and collecting the expressed polypeptide. 14. The process according to claim 13, wherein the expressing step comprises culturing a host cell transformed with the DNA molecule encoding the polypeptide. 15. The process according to claim 13, wherein the collecting step comprises one or more techniques selected from the group consisting of salting out, dialysis, filtration, concentration, gel filtration chromatography, ion-exchange chomatography, affinity chromatography, hydrophobic chromatograph, isoelectric focusing and gel electrophoresis.

Details for Patent 6,140,101

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2016-06-07